Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-100 lat
- •Potwierdzony rozpoznaniem grzybicy skóry lub zespołu Sézary'ego (stadium I-IV)
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
- •Brak zaburzeń psychicznych, które mogłyby utrudnić uczestnictwo
- •Podpisana świadoma zgoda na uczestnictwo w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- August 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Lund University Hospital
Lund, Sweden
Trial contact
Kristina Drott, MD, PhD
Jan Sundberg, RN
Kristina Drott, MD, PhD
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.